
January 28, 2025
MEC Resources Ltd (ASX: MMR, ACN 113 900 020) (“MEC” or “the Company”) is pleased to provide its Quarterly Report C Appendix 4C (“Quarterly Cashflow Report”) for the quarter ended 31 December 2024.
The Company’s primary focus in the last quarter was the completion of an Entitlement Offer, capital raising and reinstatement on the ASX.
Corporate Update
MEC reinstated to trading status on the ASX
The Company’s shares were reinstated to trading on the ASX on 2 December 2024 following suspension since 17 January 2020.
Capital Raise - Entitlement Offer
On 23 September 2024 the Company announced a pro-rata non-renounceable entitlement issue of one (1) Share for every one (1) existing Share together with 1 free attaching listed Option for every 2 Shares subscribed for and issued held by those Shareholders registered at the Record Date at an issue price of $0.005 per Share to raise up to $4,894,864 (before costs) (Entitlement Offer).
The Company lodged a prospectus for the Offer with ASIC and ASX on 23 September 2024 and Supplementary Prospectus on 11 October 2024.
The Entitlement Offer was closed on 25 October 2024 raising approximately $ 2,646,151 (before costs). The Entitlement Offer was supported by the Company’s existing shareholders with a total of $816,627 raised through acceptances, comprising 17% of the total amount sought under the rights issue.
In addition, Sixty-Two Capital Pty Ltd (lead manager to the shortfall) has placed $1,829,525 as part of the Shortfall offer, bringing the total amount raised under the Offer to $ 2,646,151. The Company issued Shares and New Options as set out below.
Click here for the full ASX Release
This article includes content from MEC Resources, licensed for the purpose of publishing on Investing News Australia. This article does not constitute financial product advice. It is your responsibility to perform proper due diligence before acting upon any information provided here. Please refer to our full disclaimer here.
The Conversation (0)
2h
Kinetiko Funded to Advance Brakfontein Development
Kinetiko Energy (KKO:AU) has announced Kinetiko Funded to Advance Brakfontein DevelopmentDownload the PDF here. Keep Reading...
13h
Kinvestor Day 2026 Virtual Investor Conference: Presentations Now Available for Online Viewing
Kin Communications ("Kin"), Canada's Leading Investor Relations Agency, is pleased to announce that presentations from the Kinvestor Day 2026 Virtual Investor Conference, held on October 22, 2026, are now available on the Kinvestor YouTube channel. Access replays:... Keep Reading...
26 October
Oil and Gas Price Trends: Q3 2026 Review and Forecast
Oil prices climbed back above US$100 per barrel in Q3 as fighting resumed in the Middle East and the Strait of Hormuz stayed largely shut. Natural gas traded in a narrow range, shielded by North America's locked-in market.The oil market spent the third quarter of 2026 caught between hopes for a... Keep Reading...
23 October
Trump Invokes Defense Production Act as Fuel Prices Climb
US President Donald Trump declared domestic oil production, refining and fuel logistics essential to national defense on Thursday (October 22), and directed the Secretary of War to finance new capacity as fuel prices climb less than two weeks before the midterm elections.In a presidential memo,... Keep Reading...
22 October
Quarterly Activities/Appendix 5B Cash Flow Report
Kinetiko Energy (KKO:AU) has announced Quarterly Activities/Appendix 5B Cash Flow ReportDownload the PDF here. Keep Reading...
21 October
Angkor Resources Presents Its Proposed 2027 Work Program For Block Viii To The Cambodian Government At The Joint Review Committee
(TheNewswire) GRANDE PRAIRIE, ALBERTA (October 21, 2026) TheNewswire - GRANDE PRAIRIE, ALBERTA (October 21, 2026): Angkor Resources Corp. (TSXV: ANK,OTC:ANKOF OTCQB: ANKOF) ("ANGKOR" OR "THE COMPANY") announces that its Cambodian energy subsidiary, EnerCam Resources Co., Ltd. ("EnerCam"),... Keep Reading...
Latest News
Interactive Chart
Latest Press Releases
Related News
TOP STOCKS
American Battery4.030.24
Aion Therapeutic0.10-0.01
Cybin Corp2.140.00




